Clinical Trials Directory

Explore 21,535 clinical trials worldwide

Showing 8801-8850 of 21,535 trials

Active filters:Status: Active, not recruiting

Clinical Trials (21,535)

NCT06884696
Study of Placental Inflammation in Gestational Diabetes
NAActive, not recruiting
40 participants
Started: Jul 1, 2022 · Completed: Jun 30, 2025
1 condition1 sponsor1 location
NCT04789070
Phase III Trial of Sirolimus in IBM
PHASE3Active, not recruiting
140 participants
Started: Jul 1, 2022 · Completed: Dec 1, 2026
1 condition2 sponsors9 locations
NCT06954259
Prognostic Correlation Between the Ratio of the Neutrophil Ratio to the Ratio of CD4+/CD8+ T Cells in Patients With Advanced Non-small Cell Lung Cancer NSCLC) Undergoing Immunotherapy Combined With Chemotherapy
N/AActive, not recruiting
272 participants
Started: Jul 1, 2022 · Completed: Jun 30, 2025
1 condition1 sponsor1 location
NCT06196749
Ultrasound-Guided Technique in Distal Radial Artery Catheterization Study
NAActive, not recruiting
112 participants
Started: Jul 1, 2022 · Completed: Jan 30, 2024
4 conditions2 sponsors1 location
NCT05383716
Neoadjuvant/Adjuvant Pembrolizumab Plus Chemotherapy
PHASE2Active, not recruiting
80 participants
Started: Jul 1, 2022 · Completed: Dec 31, 2027
3 conditions1 sponsor1 location
NCT05527054
Risk Factors and Machine Learning Model for Diuretics Related Acute Kidney Injury
N/AActive, not recruiting
18,000 participants
Started: Jul 1, 2022 · Completed: Jun 30, 2024
2 conditions1 sponsor1 location
NCT05365178
To Evaluate the Efficacy and Safety of TQB3616 in Combination With Fulvestrant Versus Placebo in Combination With Fulvestrant in Previously Untreated Hormone-receptor (HR)-Positive, Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Advanced Breast Cancer
PHASE3Active, not recruiting
432 participants
Started: Jul 1, 2022 · Completed: Jun 30, 2026
1 condition1 sponsor88 locations
NCT05037799
Dose Optimization for Rubidium PET Imaging in Patients With Known or Suspected Ischemic Heart Disease
N/AActive, not recruiting
48 participants
Started: Jul 1, 2022 · Completed: Apr 30, 2025
1 condition2 sponsors1 location
NCT06519695
Exercise Intervention for Pre-frail Elderly
NAActive, not recruiting
144 participants
Started: Jul 1, 2022 · Completed: Dec 31, 2024
1 condition1 sponsor1 location
NCT05453162
Circadian Influence on Prolonged Exposure Therapy for PTSD
NAActive, not recruiting
52 participants
Started: Jul 1, 2022 · Completed: Aug 15, 2025
1 condition3 sponsors1 location
NCT04404777
Local Recurrence Due to Rectal Cancer in Sweden
N/AActive, not recruiting
12,000 participants
Started: Jul 1, 2022 · Completed: Jun 1, 2027
1 condition1 sponsor1 location
NCT05351255
Motor Learning After Cerebellar Damage: The Role of the Primary Motor Cortex
NAActive, not recruiting
17 participants
Started: Jul 1, 2022 · Completed: Dec 19, 2026
1 condition2 sponsors1 location
NCT05455411
Parent-implemented Social Communication Treatment in Preschool Children With Autism Spectrum Disorder
NAActive, not recruiting
112 participants
Started: Jul 1, 2022 · Completed: Jun 30, 2026
5 conditions1 sponsor2 locations
NCT05360615
The Effects of Empagliflozin on Renal Outcomes in Post Severe Acute Kidney Injury Survivors
PHASE1Active, not recruiting
147 participants
Started: Jul 1, 2022 · Completed: Jul 1, 2026
1 condition1 sponsor1 location
NCT05377580
A Study to Evaluate IBI112 in the Treatment of Moderate to Severe Active Ulcerative Colitis
PHASE2Active, not recruiting
150 participants
Started: Jul 1, 2022 · Completed: Sep 30, 2025
1 condition1 sponsor1 location
NCT05605184
Anonymous Survey of Breast Cancer Patients Concerning Their Use of Medical Apps
N/AActive, not recruiting
200 participants
Started: Jul 1, 2022 · Completed: Mar 31, 2025
1 condition1 sponsor1 location
NCT06241196
Vestibular Socket Therapy Using Acellular Dermal Matrix Versus Connective Tissue Graft
PHASE2Active, not recruiting
10 participants
Started: Jul 1, 2022 · Completed: Apr 1, 2024
1 condition1 sponsor1 location
NCT06357351
Comparison of Using Collagen Membrane and A-PRF Using VISTA Technique in Gingival Recession Treatment
NAActive, not recruiting
24 participants
Started: Jul 1, 2022 · Completed: May 31, 2024
1 condition1 sponsor1 location
NCT05911165
Impact of Surgical Coaching on Resident ObGyn Laparoscopic Skills
NAActive, not recruiting
28 participants
Started: Jul 1, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT05383482
Afuresertib +Sintilimab+Chemotherapy in Patients With Selected Solid Tumors That Resistance to Prior Anti-PD-1/PD-L1
PHASE1/PHASE2Active, not recruiting
22 participants
Started: Jun 30, 2022 · Completed: Dec 31, 2025
6 conditions1 sponsor5 locations
NCT05364073
Study of Furmonertinib in Patients With Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) With Activating, Including Uncommon, Epidermal Growth Factor Receptor (EGFR) or Human Epidermal Growth Factor Receptor 2 (HER2) Mutations
PHASE1Active, not recruiting
160 participants
Started: Jun 30, 2022 · Completed: Dec 31, 2025
6 conditions1 sponsor42 locations
NCT05299502
Healthy Eating in Women at Risk of Gestational Diabetes
NAActive, not recruiting
150 participants
Started: Jun 30, 2022 · Completed: Feb 28, 2027
2 conditions3 sponsors1 location
NCT05456425
A Clinical Trial on Safety and Efficacy of CBT-001 in Patients With Pterygium
PHASE3Active, not recruiting
660 participants
Started: Jun 30, 2022 · Completed: Dec 31, 2027
1 condition1 sponsor44 locations
NCT06024694
Primary Mediastinal Large B-cell Lymphoma With CNS Involvement
N/AActive, not recruiting
45 participants
Started: Jun 30, 2022 · Completed: Jun 10, 2027
1 condition1 sponsor1 location
NCT05327296
Efficacy and Safety of Inhaled Isoflurane Delivered Via the Sedaconda ACD-S Compared to Intravenous Propofol for Sedation of Mechanically Ventilated Intensive Care Unit Adult Patients (INSPiRE-ICU2)
PHASE3Active, not recruiting
235 participants
Started: Jun 30, 2022 · Completed: Dec 30, 2024
1 condition1 sponsor16 locations
NCT05176626
Long-term Effectiveness of the Antiobesity Medication Phentermine
PHASE4Active, not recruiting
870 participants
Started: Jun 30, 2022 · Completed: Dec 31, 2026
3 conditions9 sponsors4 locations
NCT05531370
Implementation of Evidence-based Breathing Retraining for Patients with Asthma in Region Zealand
NAActive, not recruiting
300 participants
Started: Jun 30, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT06026644
Health-Related Quality of Life Outcomes in Patients With Aggressive B-Cell Lymphomas Treated With CAR-T Cell Therapy in Real Life
N/AActive, not recruiting
170 participants
Started: Jun 29, 2022 · Completed: Apr 15, 2026
1 condition1 sponsor13 locations
NCT06019507
A Study of TCD601 in the Induction of Tolerance in de Novo Liver Transplantation
PHASE2Active, not recruiting
12 participants
Started: Jun 29, 2022 · Completed: Jun 30, 2029
1 condition1 sponsor1 location
NCT05134935
Defocus (DIMS) Spectacles Versus Ortho-K Lenses (OKL) for Slowing Myopia Progression in Children Aged 6-12 Years.
NAActive, not recruiting
90 participants
Started: Jun 29, 2022 · Completed: May 31, 2026
1 condition1 sponsor1 location
NCT05257408
Relacorilant in Combination With Nab-Paclitaxel in Advanced, Platinum-Resistant, High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian-Tube Cancer
PHASE3Active, not recruiting
381 participants
Started: Jun 29, 2022 · Completed: Mar 31, 2026
3 conditions2 sponsors117 locations
NCT05102747
Stereotactic Radiotherapy in Oligometastatic Brain Disease: a Randomised Phase III Study Comparing Hypofractionated Stereotactic Radiation Therapy (3*10 Gy) to the Historical Single-dose Radiosurgery (1*20 to 25 Gy) With Medico-economic Evaluation.
NAActive, not recruiting
504 participants
Started: Jun 29, 2022 · Completed: Jun 30, 2027
2 conditions2 sponsors16 locations
NCT05479578
Cyclophosphamide and Dexamethasone for the Treatment of Metastatic Castration Resistant Prostate Cancer
PHASE1Active, not recruiting
7 participants
Started: Jun 29, 2022 · Completed: May 1, 2025
3 conditions2 sponsors1 location
NCT05173961
A Mobile Application, Oncpatient, to Assist Patients Undergoing Radiation Therapy
NAActive, not recruiting
20 participants
Started: Jun 29, 2022 · Completed: Nov 30, 2025
2 conditions2 sponsors1 location
NCT05164016
Evaluating Immune Response to COVID-19 Vaccines in Patients With Cancer, Transplant or Cellular Therapy Recipients
N/AActive, not recruiting
21 participants
Started: Jun 29, 2022 · Completed: Dec 31, 2027
8 conditions1 sponsor3 locations
NCT05421780
Post-prandial Glycaemic Controlling Effects of BSG in Singapore Adults With Metabolic Syndrome
NAActive, not recruiting
16 participants
Started: Jun 29, 2022 · Completed: Jul 31, 2024
3 conditions2 sponsors1 location
NCT05334719
A Study of the Effectiveness and Safety of Nivolumab Plus Chemotherapy in Participants With Untreated Advanced/Recurrent Gastric Cancer
N/AActive, not recruiting
500 participants
Started: Jun 29, 2022 · Completed: Sep 30, 2026
1 condition2 sponsors1 location
NCT04939272
Copanlisib and Venetoclax for the Treatment of Relapsed or Refractory Mantle Cell Lymphoma
PHASE1/PHASE2Active, not recruiting
8 participants
Started: Jun 29, 2022 · Completed: Feb 24, 2026
2 conditions2 sponsors1 location
NCT05356702
The Brain Health Study: A Pragmatic, Patient-Centered Trial
NAActive, not recruiting
3,417 participants
Started: Jun 29, 2022 · Completed: Apr 15, 2025
2 conditions2 sponsors5 locations
NCT05382364
Safety and Pharmacokinetics of Tucatinib (MK-7119) in Chinese Participants With Cancer (MK-7119-002)
PHASE1Active, not recruiting
25 participants
Started: Jun 29, 2022 · Completed: Dec 31, 2025
4 conditions1 sponsor5 locations
NCT05389371
OA Optimization Program Pilot Trial
PHASE1/PHASE2Active, not recruiting
70 participants
Started: Jun 28, 2022 · Completed: Sep 30, 2025
4 conditions2 sponsors1 location
NCT05399654
A Dose Escalation and Expansion Study of TAC-001 in Patients With Select Advanced or Metastatic Solid Tumors
PHASE1/PHASE2Active, not recruiting
72 participants
Started: Jun 28, 2022 · Completed: May 19, 2026
1 condition1 sponsor12 locations
NCT05173818
Hyperbaric Oxygen Effects on Persistent Post-concussive Symptoms
PHASE2Active, not recruiting
40 participants
Started: Jun 28, 2022 · Completed: Sep 30, 2025
2 conditions5 sponsors1 location
NCT05405660
A Study of CDX-0159 in Patients With Chronic Inducible Urticaria
PHASE2Active, not recruiting
196 participants
Started: Jun 28, 2022 · Completed: Sep 30, 2025
1 condition1 sponsor76 locations
NCT05878691
A Study of GRC 54276 in Participants With Advanced Solid Tumors and Lymphomas.
PHASE1Active, not recruiting
320 participants
Started: Jun 28, 2022 · Completed: Jul 30, 2027
2 conditions1 sponsor18 locations
NCT05461339
TAB014 Compared to Lucentis® in Patients with Neovascular Age-related Macular Degeneration
PHASE3Active, not recruiting
488 participants
Started: Jun 28, 2022 · Completed: Feb 28, 2025
1 condition2 sponsors56 locations
NCT05281328
A Trial to Assess the Efficacy and Safety of Octreotide Subcutaneous Depot in Patients With PLD
PHASE2/PHASE3Active, not recruiting
71 participants
Started: Jun 28, 2022 · Completed: Aug 31, 2027
1 condition1 sponsor11 locations
NCT05286294
Microbiota Transplant to Cancer Patients Who Have Failed Immunotherapy Using Faeces From Clinical Responders
PHASE2Active, not recruiting
20 participants
Started: Jun 28, 2022 · Completed: Dec 31, 2034
6 conditions1 sponsor1 location
NCT05393258
Temporally-modulated Pulsed Radiation Therapy (TMPRT) After Prior EBRT for Recurrent IDH-mutant Gliomas
NAActive, not recruiting
13 participants
Started: Jun 28, 2022 · Completed: May 27, 2026
3 conditions1 sponsor1 location
NCT05319431
A Phase II Study of AK104 Plus Lenvatinib and TACE in HCC
PHASE2Active, not recruiting
60 participants
Started: Jun 28, 2022 · Completed: Jun 30, 2025
1 condition1 sponsor5 locations